Global Spinal Fusion Device Market Analysis

The Global Spinal Fusion Device Market is projected to reach approximately US$9.99 billion by 2030, according to Renub Research. Spinal fusion surgery is performed to address disorders of the spine, specifically targeting the fusion of two or more vertebrae. This surgical procedure is used to treat conditions such as degenerative disc disease, fractured vertebrae, spondylolisthesis, disc herniation, and spinal canal stenosis. In recent years, the demand for spinal fusion surgeries has been steadily increasing, primarily due to the rising prevalence of spinal deformities associated with aging, motor vehicle accidents, falls, and violence.

Spinal fusion devices are essential for correcting spinal deformities, and their market growth is driven by an expanding geriatric population and a rising incidence of spinal disorders. The indications for spinal fusion surgery have also broadened; initially performed mainly for scoliosis and spinal tuberculosis, it is now indicated for 14 different conditions. For example, in 2020, the U.S. recorded 153,288 anterior cervical discectomy and fusions, with this number anticipated to increase by 13.3% by 2040.

The market is expected to grow at a CAGR of 3.98% from 2024 to 2030. As global demographics shift towards an aging population, the need for managing age-related spine disorders is becoming increasingly critical. The World Health Organization predicts that by 2030, 1 in 6 individuals will be aged 60 or older, with the number of seniors projected to rise from 1 billion in 2020 to 1.4 billion by 2050. Additionally, the population aged 80 and above is expected to triple to 426 million during the same period. These demographic changes, coupled with extended exposure to risk factors, are contributing to a heightened prevalence of spinal disorders requiring surgical intervention.

According to a 2022 report on spinal cord injuries, between 250,000 and 500,000 individuals worldwide sustain spinal cord injuries each year, primarily due to preventable causes such as violence and vehicular accidents. In the U.S., approximately 17,000 new cases are reported annually, with around 282,000 individuals currently living with spinal cord injuries. The highest incidence of spinal cord injuries occurs in males aged 16 to 30, highlighting the growing demand for spinal fusion devices.

The trend toward minimally invasive surgical techniques is also propelling market growth. These procedures offer numerous benefits, including reduced recovery times and less postoperative discomfort. For instance, single-position anterior lumbar fusion allows surgeons to perform the entire operation while the patient is positioned on their side. In November 2022, Sentinel Spine LLC published a peer-reviewed study on its STALIF M product line, which has a proven track record of over 75,000 devices implanted.

Market Segmentation

Cervical Segment Growth

The cervical segment of spinal fusion devices is expected to experience significant growth in the coming years. This sector is anticipated to expand due to technological advancements, increased patient awareness, and a rising incidence of cervical spine-related issues. Companies in the spinal fusion device market are focusing on innovation to meet the growing demand in this area.

Dominance of Minimally Invasive Surgery

The minimally invasive surgery segment holds the largest revenue share in the spinal fusion device market. This segment has gained popularity due to its associated benefits, such as smaller incisions and shorter recovery times, making it a preferred choice for patients and healthcare providers. The increasing preference for less invasive surgical techniques underscores the importance of innovation and efficiency within the medical field.

Hospital-Based Market Share

By end user, hospitals dominate the spinal fusion device market, holding the largest market share. This is attributed to the high volume of spinal fusion procedures performed in hospital settings, where comprehensive spinal care services can be provided. Hospitals are well-equipped to handle complex spinal surgeries, reinforcing their critical role in the spinal fusion devices market.

Regional Insights

Growth in Asia-Pacific

The Asia-Pacific region is poised for substantial growth in the spinal fusion device market, driven by an aging population and increasing road traffic accidents. Projections indicate that this market will expand rapidly due to several factors, including a growing elderly population, rising spinal disorder incidences, and advancements in medical technology. As healthcare infrastructure improves and awareness of treatment options rises, the demand for spinal fusion devices in this region is expected to escalate. This growth reflects the evolving healthcare landscape in countries like China and India, with a commitment to addressing spinal health issues.

Key Players

Prominent participants in the spinal fusion device market include Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings, Orthofix Medical Inc., NuVasive Inc., Globus Medical Inc., Xtant Medical Holdings, and Alphatec Holdings Inc. These companies are significant contributors to market innovation and development, enhancing treatment options for patients with spinal disorders.

Related Report :

Baby Oral Care Products Market

Peripheral Vascular Devices Market

Photodynamic Therapy Market

Product Type – Market Breakup has been covered from 4 viewpoints

1. Cervical Devices
2. Thoracolumbar Devices
3. Interbody Devices
4. Biologics

Surgery Type – Market Breakup has been covered from 2 viewpoints

1. Open Surgery
2. Minimally Invasive

End Users – Market Breakup has been covered from 3 viewpoints

1. Hospitals
2. Specialty Clinics
3. Others

Regions – Market Breakup has been covered from 5 viewpoints

1. North America

1.1    United States

1.2    Canada

2. Europe

2.1    France

2.2    Germany

2.3    Italy

2.4    Spain

2.5    United Kingdom

2.6    Belgium

2.7    Netherland

2.8    Turkey

3. Asia Pacific

3.1    China

3.2    Japan

3.3    India

3.4    South Korea

3.5    Thailand

3.6    Malaysia

3.7    Indonesia

3.8    Australia

3.9    New Zealand

4. Latin America

4.1    Brazil

4.2    Mexico

4.3    Argentina

5. Middle East & Africa

5.1    Saudi Arabia

5.2    UAE

5.3    South Africa

Company Insights:

• Overview
• Recent Development
• Revenue

Company Analysis:

1. Medtronic Plc
2. Stryker Corporation
3. Zimmer Biomet Holdings
4. Orthofix Medical Inc.
5. NuVasive Inc.
6. Globus Medical Inc.
7. Xtant Medical Holdings
8. Alphatec Holdings Inc.

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com

Naijamatta is a social networking site,

download Naijamatta from Google play store or visit www.naijamatta.com to register. You can post, comment, do voice and video call, join and open group, go live etc. Join Naijamatta family, the Green app.